i
Off-Label Use of Bedaquiline in Children and Adolescents with Multidrug-Resistant Tuberculosis
-
Oct 17 2017
-
-
Source: Emerg Infect Dis. 23(10):1711-1713.
Details:
-
Alternative Title:Emerg Infect Dis
-
Personal Author:
-
Description:We describe 27 children and adolescents <18 years of age who received bedaquiline during treatment for multidrug-resistant tuberculosis. We report good treatment responses and no cessation attributable to adverse effects. Bedaquiline could be considered for use with this age group for multidrug-resistant tuberculosis when treatment options are limited.
-
Subjects:
-
Source:
-
Pubmed ID:28758889
-
Pubmed Central ID:PMC5621552
-
Document Type:
-
Place as Subject:
-
Location:
-
Volume:23
-
Issue:10
-
Collection(s):
-
Main Document Checksum:
-
Download URL:
-
File Type: